Learn More
Selleck Chemical LLC Trimetazidine dihydrochloride S4543-1g

Supplier: Selleck Chemical LLC S45431G
Trimetazidine dihydrochloride (Yoshimilon Kyurinett Vastarel F) is a kind of drug for treatment of chronic ischemic disorders It improves myocardial glucose utilization through inhibition of fatty acid metabolism known as fatty acid oxidation inhibitor
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.